Navigation Links
Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market

VALENCIA, Calif., Dec. 2 /PRNewswire/ -- The Alfred E. Mann Foundation for Biomedical Engineering (AEMFBE), a philanthropic organization created by billionaire Alfred E. Mann to establish university-based commercialization- enablement institutes at elite universities, designed to facilitate biomedical product development for the benefit of society, today announced the launch of a Web site (

Features of the web site include:

-- Overview of Alfred Mann Institutes for Biomedical Development (AMIs), including the infrastructure and process that are created by the minimum of $100 million endowment to establish each Institute. To date, three Alfred Mann Institutes have been endowed: University of Southern California (Los Angeles), which became operational in 2001 as a test-bed for the development for future AMIs; the Technion (Haifa, Israel), 2007; and Purdue University (West Lafayette, Indiana.), 2008.

-- Background and accomplishments of Mr. Mann, who has dedicated most of his career to bettering the quality of life for those who suffer from life debilitating disorders through the development of innovative medical devices.

-- "Commercialize Your Idea," which provides insight into the developmental steps for a biomedical technology including proof of concept, FDA regulatory approval, reimbursement strategies, technology licensing considerations, etc., with an emphasis toward researchers involved in this space.

"The AMI concept has drawn a phenomenal response, both nationally and internationally, as a new model for technology transfer, a form of venture philanthropy," said A. Stephen Dahms, Ph.D., President and CEO of the AEMFBE. "The Web site addresses researchers' frequently asked questions and provides an overview of the AMI selection and creation process."

About Alfred Mann

Alfred Mann's philanthropic mission is to create and expedite the delivery of life-improving biomedical products to patients. Mann is chairman of the boards of directors for the Alfred Mann Institutes for Biomedical Development at USC, Purdue and the Technion. Mann also is chairman and chief executive officer of MannKind Corp.; chairman of Advanced Bionics Corp, Second Sight LLC, Bioness Inc., Quallion LLC and Implanted Acoustics; and chairman emeritus of Pacesetter System Inc. and MiniMed. All of these highly successful companies were founded by Mann.

About the Mann Foundation for Biomedical Engineering

Headquartered in the 167-acre Mann Biomedical Park in Valencia, Calif., the Alfred Mann Foundation for Biomedical Engineering (AEMFBE) is a philanthropic organization that establishes university-based institutes (AMIs) designed to enable biomedical product development for the benefit of mankind. The AEMFBE supports the AMIs with a variety of services, including market analysis and due diligence, valuation and exit strategy, regulatory and reimbursement guidance, cost of goods analysis and other product development activities required to expedite technologies from development to commercialization.


     Nancy Patterson
     Vice President

SOURCE Alfred E. Mann Foundation for Biomedical Engineering
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Childrens Health Care
2. HEALTHeCAREERS Network Pledges $15,000 to ASRT Foundation for Professional Healthcare Training
3. Stem Cell Sciences Enters into Services Agreement with Huntingdons Disease Research Group, CHDI Foundation Inc.
4. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
5. Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health
6. Canary Foundations Dr. Sanjiv Sam Gambhir Elected to the National Academies Institute of Medicine
7. Michael J. Fox Foundation Awards $2 Million Grant From EMD Serono to Research Projects on Cognitive Deficits in Parkinsons Disease
8. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
9. Mirixa Corporation and the APhA Foundation Form Partnership
10. GBS/CIDP Foundation to Hold 10th International Symposium
11. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... SAN FRANCISCO , June 22, 2016  Amgen ... platinum sponsorship of the QB3@953 life sciences ... improve human health. The shared laboratory space at QB3@953 ... startups overcome a key obstacle for many early stage ... As part of the sponsorship, Amgen launched two "Amgen ...
(Date:6/22/2016)... Research and Markets has announced the addition ... their offering. The global ... billion in 2013. The market is expected to grow at a ... 2020, increasing from $50.6 billion in 2015 to $96.6 billion in ... forecast period (2015 to 2020) are discussed. As well, new products ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):